As seen in Figure 2, Green identifies the network’s association with the regulation of lipid metabolism, and the PPAR signaling pathway highlights the impact of PFAS on lipid homeostasis, potentially contributing to disorders such as dyslipidemia or fatty liver disease. The gene discussed is PPARA; the disease is fatty liver disease.